Trials / Recruiting
RecruitingNCT06446869
Menopausal Symptoms Probiotic Study
Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of the Combination of Levilactobacillus Brevis KABP-052, Lactiplantibacillus Plantarum KABP-051 and Pediococcus Acidilactici KABP-021 on Menopausal Symptoms and Quality of Life in Peri- and Post-menopausal Women
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Community Pharmacology Services Ltd · Academic / Other
- Sex
- Female
- Age
- 42 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
In this study, we want to investigate if the active product consisting of a probiotic blend can potentiate the recirculation of active oestrogens into the bloodstream and help to mitigate menopause symptoms, which are closely related to oestrogens levels
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Gyntima Menopause | Combination of Levilactobacillus brevis KABP-052, Lactiplantibacillus plantarum KABP-051 and Pediococcus acidilactici KABP-021 |
| OTHER | Placebo | Placebo comparator |
Timeline
- Start date
- 2024-09-10
- Primary completion
- 2026-07-25
- Completion
- 2026-10-25
- First posted
- 2024-06-06
- Last updated
- 2026-01-26
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06446869. Inclusion in this directory is not an endorsement.